glp-1 medications for obesity Comparing Ozempic, Wegovy and Other Drugs The GLP-1 revolution: What UAB

Results vary depending on individual factors and adherence to the prescribed treatment plan

These cardiovascular factors increase the patients overall risk of mortality and morbidity due to potential cardiovascular events such as a myocardial infarction or stroke 1

Nevertheless, there is no doubt that GLP-1 interacts with vagal afferent neurons and the arcuate nucleus of the hypothalamus, critical components of the gut-brain axis that connect peripheral metabolic signals to the central nervous system [10]

Stigma: These medications should help us understand obesity as a chronic, biologically driven disease

Kolding L, Henriksen JN, Saedder EA, Ovesen PG, Pedersen LH